AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 56 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1 | – | 2,800 | +4900.0% | 0.00% | – |
Q1 2023 | $0 | – | 56 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 56 | -99.6% | 0.00% | – |
Q3 2022 | $6,000 | – | 13,121 | +100830.8% | 0.00% | – |
Q2 2022 | $0 | – | 13 | -89.8% | 0.00% | – |
Q4 2020 | $0 | – | 127 | +101.6% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 63 | -91.7% | 0.00% | – |
Q2 2020 | $6,000 | – | 756 | +2600.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 28 | -96.1% | 0.00% | – |
Q4 2019 | $5,000 | -50.0% | 725 | -44.5% | 0.00% | – |
Q3 2019 | $10,000 | -28.6% | 1,307 | -38.6% | 0.00% | – |
Q2 2019 | $14,000 | – | 2,129 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |